US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:

Therapeutic Area: CVD Prevention – Primary and Secondary Background: Aspirin for the primary prevention of cardiovascular disease (CVD) remains controversial. The 2022 US Preventive Services Task Force (USPSTF) guidelines give a grade C recommendation to consider aspirin use for primary prevention i...

Full description

Bibliographic Details
Main Authors: Athena L. Huang, MD, Ann Marie Navar, MD, PhD, Colby Ayers, MS, Anand Rohatgi, MD, MSCS, Erin Michos, MD, MHS, Salim Virani, MD, PhD, Parag Joshi, MD, MHS, Eric Peterson, MD, MPH, Amit Khera, MD, MSc
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:American Journal of Preventive Cardiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667723001046

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723001046

Similar Items